Canada markets open in 5 hours 49 minutes

Royalty Pharma plc (RPD.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
40.97-0.12 (-0.28%)
As of 08:38AM CEST. Market open.
Full screen
Previous Close41.08
Open40.08
Bid41.09 x N/A
Ask43.02 x N/A
Day's Range40.97 - 40.97
52 Week Range29.60 - 42.40
Volume240
Avg. Volume41
Market Cap28.415B
Beta (5Y Monthly)0.37
PE Ratio (TTM)29.90
EPS (TTM)1.37
Earnings DateN/A
Forward Dividend & Yield0.73 (1.81%)
Ex-Dividend DateMay 19, 2022
1y Target Est51.43
  • Simply Wall St.

    What Kind Of Shareholders Hold The Majority In Royalty Pharma plc's (NASDAQ:RPRX) Shares?

    A look at the shareholders of Royalty Pharma plc ( NASDAQ:RPRX ) can tell us which group is most powerful. Institutions...

  • GlobeNewswire

    Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to $340 Million

    Attractive, precision oncology therapy with long patent duration added to portfolioBlueprint Medicines to receive $175 million upfront and $165 million in potential milestone payments NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired an ex-U.S. royalty interest in Gavreto (pralsetinib) from Blueprint Medicines (Nasdaq: BPMC) for up to $340 million, consisting of $175 million upfront and up to $165 million in potential sales-based m

  • GlobeNewswire

    Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

    NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022 at 2:20 p.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of bio